Display options
Share it on

Prev Med Rep. 2020 Apr 02;18:101088. doi: 10.1016/j.pmedr.2020.101088. eCollection 2020 Jun.

Persistent tobacco smoke residue in multiunit housing: Legacy of permissive indoor smoking policies and challenges in the implementation of smoking bans.

Preventive medicine reports

Georg E Matt, Penelope J E Quintana, Eunha Hoh, Joy M Zakarian, Nathan G Dodder, Rachael A Record, Melbourne F Hovell, E Melinda Mahabee-Gittens, Samuel Padilla, Laura Markman, Kayo Watanabe, Thomas E Novotny

Affiliations

  1. San Diego State University Department of Psychology, San Diego, CA, USA.
  2. San Diego State University School of Public Health, San Diego, CA, USA.
  3. San Diego State University Research Foundation, San Diego, CA, USA.
  4. San Diego State University School of Communication, San Diego, CA, USA.
  5. Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, OH, USA.

PMID: 32368436 PMCID: PMC7186560 DOI: 10.1016/j.pmedr.2020.101088

Abstract

Secondhand smoke (SHS) is a common indoor pollutant in multiunit housing (MUH). It is also the precursor of thirdhand smoke (THS), the toxic mixture of tobacco smoke residue that accumulates in indoor environments where tobacco has been used. This study examined the levels, distribution, and factors associated with THS pollution in low-income MUH. Interviews were conducted 2016-2018 in a cross-sectional study of N = 220 MUH homes in San Diego, California. Two surface wipe samples were collected per home and analyzed for nicotine, a THS marker, using liquid chromatography-triple quadrupole mass spectrometry. Nicotine was detected in all homes of nonsmokers with indoor smoking bans (Geo Mean = 1.67 µg/m

© 2020 The Authors.

Keywords: Housing; MUH, Multiunit Housing; Nicotine; Policies; SHS, Secondhand Smoke; THS, Thirdhand Smoke; Tobacco smoke pollution

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

References

  1. Tob Control. 2016 Sep;26(5):548-556 - PubMed
  2. Chem Res Toxicol. 2013 Nov 18;26(11):1615-31 - PubMed
  3. Am J Public Health. 2012 Oct;102(10):1868-71 - PubMed
  4. Environ Sci Technol. 2006 Mar 15;40(6):1799-805 - PubMed
  5. Am J Health Promot. 2011 May-Jun;25(5 Suppl):S82-90 - PubMed
  6. Nicotine Tob Res. 2015 Feb;17(2):256-8 - PubMed
  7. Tob Control. 2017 Jan;26(1):113-117 - PubMed
  8. J Subst Abuse Treat. 2018 Nov;94:9-17 - PubMed
  9. Mutagenesis. 2013 Jul;28(4):381-91 - PubMed
  10. Tob Control. 2011 Jan;20(1):e1 - PubMed
  11. Tob Control. 2013 May;22(3):201-7 - PubMed
  12. Int J Mol Sci. 2017 Apr 28;18(5): - PubMed
  13. Tob Control. 2009 Dec;18(6):438-44 - PubMed
  14. J Clin Outcomes Manag. 2017 Dec;24(12):551-559 - PubMed
  15. Tob Control. 2018 Nov;27(6):643-649 - PubMed
  16. Int J Drug Policy. 2015 Jun;26(6):609-11 - PubMed
  17. Nicotine Tob Res. 2019 Nov 19;21(12):1680-1688 - PubMed
  18. Sci Adv. 2020 Mar 04;6(10):eaay4109 - PubMed
  19. Public Health Rep. 2017 Nov/Dec;132(6):637-645 - PubMed
  20. Pediatrics. 2011 Jan;127(1):85-92 - PubMed
  21. Toxicol In Vitro. 2016 Apr;32:220-31 - PubMed
  22. Tob Control. 2018 Mar;27(2):194-202 - PubMed
  23. PLoS One. 2014 Jan 29;9(1):e86391 - PubMed
  24. Environ Health Perspect. 1999 May;107 Suppl 2:319-27 - PubMed
  25. Nicotine Tob Res. 2016 May;18(5):1290-8 - PubMed
  26. Nicotine Tob Res. 2010 Jun;12(6):598-605 - PubMed
  27. Nicotine Tob Res. 2007 Jan;9 Suppl 1:S39-47 - PubMed
  28. J Cardiovasc Pharmacol. 2015 Aug;66(2):177-82 - PubMed
  29. Sci Rep. 2019 Dec 9;9(1):18587 - PubMed
  30. Tob Control. 2019 Sep;28(5):519-525 - PubMed
  31. Tob Control. 2014 Jan;23(1):27-32 - PubMed
  32. Toxicol Sci. 2016 Mar;150(1):234-46 - PubMed
  33. Environ Health Perspect. 2011 Sep;119(9):1218-26 - PubMed
  34. Tob Use Insights. 2019 Jan 16;12:1179173X18823493 - PubMed
  35. Tob Control. 2014 May;23(3):264-72 - PubMed
  36. Toxicol Sci. 2016 Sep;153(1):55-69 - PubMed
  37. Tob Control. 2004 Mar;13(1):29-37 - PubMed
  38. Nicotine Tob Res. 2014 Jul;16(7):961-75 - PubMed
  39. Public Health Rep. 2016 Mar-Apr;131(2):233-8 - PubMed
  40. Nicotine Tob Res. 2019 Aug 19;21(9):1294-1296 - PubMed
  41. Nicotine Tob Res. 2018 Feb 7;20(3):303-311 - PubMed
  42. Nicotine Tob Res. 2008 Sep;10(9):1467-75 - PubMed
  43. Tob Control. 2016 Jan;25(1):9-20 - PubMed
  44. Zhonghua Yu Fang Yi Xue Za Zhi. 2015 Jan;49(1):31-5 - PubMed
  45. Tob Control. 2014 Mar;23(2):152-9 - PubMed
  46. Chest. 2016 Feb;149(2):552-561 - PubMed
  47. Sci Rep. 2015 Oct 22;5:15512 - PubMed
  48. Tob Control. 2018 Mar;27(2):217-219 - PubMed
  49. Environ Res. 2019 Jan;168:206-210 - PubMed
  50. Prev Chronic Dis. 2015 Jun 25;12:E98 - PubMed
  51. J Expo Anal Environ Epidemiol. 2002 Jul;12(4):259-64 - PubMed
  52. Birth Defects Res C Embryo Today. 2016 Jun;108(2):181-92 - PubMed
  53. Environ Sci Technol. 2002 Mar 1;36(5):846-53 - PubMed
  54. PLoS One. 2014 Oct 06;9(10):e108258 - PubMed
  55. Tob Control. 2016 Nov;25(6):619-623 - PubMed
  56. Neurosci Biobehav Rev. 2017 Jan;72:176-189 - PubMed
  57. Clin Sci (Lond). 2018 Feb 28;132(4):475-488 - PubMed
  58. Drug Test Anal. 2016 Jul;8(7):676-81 - PubMed
  59. Nicotine Tob Res. 2013 Sep;15(9):1555-63 - PubMed
  60. Environ Sci Technol. 2014 Nov 18;48(22):13093-101 - PubMed
  61. Chem Res Toxicol. 2017 Jan 17;30(1):270-294 - PubMed
  62. Risk Anal. 2007 Apr;27(2):411-20 - PubMed

Publication Types

Grant support